Now’s time to declare war on antibiotic resistance
A month before allied forces stormed the beaches of Normandy on June 6, 1944, Time magazine featured Dr. Alexander Fleming on its cover. The photo caption read: "His penicillin will save more lives than war can spend."
I have been a pediatrician for nearly 40 years, and I can attest that penicillin and other antibiotics have kept the promise Time boldly made amid a world war.
Unfortunately, I am equally aware that these drugs are rapidly losing their effectiveness, that children are still suffering from deadly infections as a result, and that we are running out of new antibiotics to treat them.
In response to these trends, the World Health Organization has dedicated today — World Health Day - to fighting the spread of antibiotic resistance. We must take this opportunity to acknowledge that we need new antibiotics and we need them now.
Fleming's discovery of penicillin heralded the dawn of the antibiotic era. Once-incurable infections were easily healed. Bacteria, however, have been adapting and evolving for eons - and for the last several decades, they have grown increasingly resistant to the antibiotics we invented to kill them.
We kept pace with antibiotic resistance for 33 years. The period between 1935 and 1968 was a golden age that saw the introduction of 13 novel classes of the drugs, each of which attacked bacteria in unique ways.
But all of a sudden, the pipeline of new antibiotics went dry. No new antibiotic classes were introduced between 1969 and 2000, and only two have been introduced since.
As a result, we do not have enough new medicines to fight drug-resistant superbugs and unless we do something to change that, we will find ourselves returning to a world without antibiotics. Infections and medical procedures considered innocuous today will become as dangerous as they were before Fleming's miraculous discovery.
Children are increasingly being infected with methicillin-resistant Staphylococcus aureus, commonly known as MRSA. This drug-resistant bug kills 19,000 Americans each year, and a growing number of infections are being acquired outside of hospitals. At Texas Children's Hospital, about 70 percent of the Staphylococcus aureus isolates from children who developed their infections in the community are MRSA.
Medicines Act 1968 - News
As a result, we do not have enough new medicines to fight drug-resistant superbugs and unless we do something to change that, we will find ourselves returning to a world without antibiotics. Infections and medical procedures considered innocuous today

The sheriffs argue that the 1968 US Gun Control Act prohibits selling firearms to drug addicts, and they say that includes medical marijuana card holders. Their briefs state that they cannot give a permit to carry a gun to someone prohibited from
The sheriffs argue that the 1968 US Gun Control Act prohibits selling firearms to drug addicts, and they say that includes medical marijuana card holders. Their briefs state that they cannot give a permit to carry a gun to someone prohibited from
"Because these are prescription drugs, which would likely be subject to 'Barak-O-care' style entitlements and subsidies, the government is already paring back on medicines doctors may use to treat their patients," England argues.
Section 12(1) of the Medicines Act 1968 « The Herbarium
The disagreement between herbalists who want to be recognised by the state and those who don’t want to be organised is as old as the hills. Those of you who have willed for statutory regulation (SR) are on the eve of achieving your dream, and we hope you will make the very best you are able of the trials and the opportunities it will present. However, there is one last bit of business to attend to, which might even unite us briefly, in countering the proposal to reform Section 12(1) of the Medicines Act 1968. We hope you will take up this cause as it profoundly affects the future and security of those choosing to work in a regulated environment, as well as the rest of us.
Firstly, here is Section 12(1) itself:
Section
Secondly, here is an extract from the statement released by the MHRA on February 16th 2011:
‘If practitioner regulation is in place for the purposes of creating an Article 5(1) scheme this also opens the way to reform Section 12 (1) of the Medicines Act 1968. Under Section 12 (1), practitioners may prepare unlicensed herbal medicines on their own premises for use following consultation with individual patients. It is intended to move to the position that only registered practitioners would be able to operate under Section 12 (1) after regulation of practitioners is in place.’* need to keep Section 12(1) of the Medicines Act 1968 unchanged
To the UK Government: Reforming 12(1) is not necessary to comply with the Traditional Herbal Medicine Products Directive (THMPD). Restricting all unlicensed medicines to the exclusive use of regulated practitioners would effectively outlaw the many herbalists who will not register with the HPC. This is not simply a matter of bowing to pressure groups or even the wishes of the majority: it’s also important to protect individual choice, applicable where such choices neither cost the public purse nor cause harm. Those who for whatever reason choose to consult with unregulated herbalists should still be able to do so legally under the caveat emptor required in order to achieve a workable regulatory process. It would leave you vulnerable if SR founders on inception or in the future, or if at any stage you personally opt to become deregulated (as so many osteopaths and chiropractors have in recent times). It may also pave the way to the removal of the right of registered practitioners to make their own medicines, and there would be nothing anybody could do about it.
Medicines Act 1968 - Bookshelf
Medicines Act 1968, guidance notes on applications for product licences
Medicines act 1968
Medicines Act 1968, guidance notes on applications for clinical trials certificates and clinical trial exemptions
Medicines act 1968
Medicines Act 1968, proposed amendments to the medicines (exemption from licences) (clinical trials) order 1981 S.I. 1981/164 : [letter from] Department of Health and Social Security
Everyday Info Directory
Medicines Act 1968
An Act to make new provision with respect to medicinal products and related matters, and for purposes connected therewith.
Medicines Act 1968 - Wikipedia, the free encyclopedia
The Medicines Act 1968 is an Act of Parliament of the United Kingdom. ... The act defines three categories of medicine: prescription only medicines (POM), which ...
Medicines Act 1968: Legal Guidance: the Crown Prosecution Service
Crown Prosecution Service Guidance on Medicines Act 1968 ... The Medicines Act 1968 exists to protect patients from unscrupulous suppliers of medicines. ...
Medicines Act 1968 - Ganfyd
The Medicines Act 1968. You might also wish to look at amendments of which a randomly ... The Medicines Act 1968 divides medicines into three categories as follows (list may be ...
Amendments to the Medicines Act 1968
(1) In section 10 of the Medicines Act 1968 (c. 67) (which provides for exemptions for ... (1) For section 71 of the Medicines Act 1968 (pharmacy business carried on by body ...